Global Direct-to-consumer Disease Risk and Health Genetic Test Market, By Type (Celiac Disease, Parkinson Disease, Alzheimer Disease), By Application, and By Region - Trends and Forecast Analysis, 2021-2035

Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size is expected to reach USD 27.64 Billion by 2035 from USD 5.23 Billion in 2024, with a CAGR of around 16.33% between 2024 and 2035. The global direct-to-consumer disease risk and health genetic test market is driven by increasing consumer demand for personalized health insights and the growing shift toward preventive healthcare. As people become more aware of the importance of early diagnosis, genetic testing has been embraced as a proactive tool for managing future health risks. Tests for conditions like cancer, diabetes, and cardiovascular diseases are now widely used by individuals aiming to make informed lifestyle choices. However, the market faces a restraint in the form of data privacy concerns. Consumers have raised issues about how genetic information is stored and shared, leading to hesitation in adopting these tests. Despite this, two key opportunities have emerged. The first is the integration of genetic testing with digital health platforms, allowing users to receive real-time health advice and manage their conditions more effectively. For example, DNA testing services have been paired with fitness apps to recommend tailored exercise routines. The second opportunity lies in expanding the availability of genetic tests in emerging markets. Countries in Latin America and Asia-Pacific are seeing an increase in DNA test adoption as health awareness rises and digital infrastructure improves. These opportunities are expected to fuel the market's growth and broaden its reach globally.

Driver: Personalized Health Insights Drive Demand

One major driver of the global direct-to-consumer disease risk and health genetic test market is the increasing demand for personalized health insights. As individuals become more health-conscious, they are turning to genetic testing to better understand their unique health risks and make more informed lifestyle choices. For instance, in the United States, people with a family history of hereditary conditions like breast cancer are using genetic tests to assess their risk and take preventive measures. In countries like India, the growing middle class is seeking genetic testing to understand risks related to diabetes and heart disease, which are becoming more prevalent in the region. These tests not only help identify genetic predispositions but also offer guidance on nutrition, exercise, and other wellness practices tailored to the individual’s genetic makeup. In the UK, wellness centers have partnered with genetic testing companies to provide customers with personalized diet and fitness plans based on their genetic data. As people continue to shift their focus from reactive to proactive healthcare, the demand for such personalized services has surged. With better awareness and technological advancements, personalized genetic health insights have become a key tool for people seeking to optimize their long-term well-being.

Key Insights:

• Over 45% of adults in the U.S. have considered using a direct-to-consumer genetic health test.
• A leading genetic testing company recently invested over USD 300 million to expand its product offerings in health genetics.
• More than 25 million direct-to-consumer genetic health tests have been sold globally in the last three years
• In Europe, the penetration of genetic testing services among healthcare providers reached approximately 15% in 2023.
• Over 60% of genetic testing consumers in Asia-Pacific report using the service for disease risk assessments and preventive care.
• A government-backed health initiative in Canada allocated USD 50 million to integrate genetic testing into public healthcare programs.
• Approximately 35% of individuals who use genetic health tests subscribe to follow-up consultations for personalized health plans.
• The number of online health and genetic testing services has increased by over 40% in North America in the past five years.

Segment Analysis:

The direct-to-consumer disease risk and health genetic test market is growing with diverse offerings across both types and applications. For Type, testing for Celiac disease has gained traction, especially among individuals with digestive issues or unexplained discomfort. In countries like Italy, where Celiac disease is more common, individuals use genetic tests to confirm their predisposition and make dietary adjustments. Tests for Parkinson’s disease are also on the rise, with many individuals seeking early detection due to family history or symptoms like tremors. These tests are particularly popular in North America and Europe, where awareness of neurological conditions is high, helping patients make early lifestyle changes. Alzheimer’s disease testing is becoming increasingly common, particularly among individuals with a family history of dementia, as it offers insights into their risk of developing the condition later in life. In application, the online segment dominates, as consumers increasingly prefer the convenience of ordering tests from home. In countries like South Korea, users commonly purchase genetic health tests through online platforms, receiving results via mobile apps. However, the offline segment remains important, particularly in regions where digital access is limited or older populations prefer face-to-face consultations. For instance, in rural parts of Eastern Europe, offline channels still play a vital role in delivering genetic testing services.

Regional Analysis:

The direct-to-consumer disease risk and health genetic test market shows varying trends across regions, shaped by cultural attitudes and healthcare access. In North America, the market is thriving, driven by high awareness of genetic testing for disease prevention. In the U.S., individuals are increasingly using genetic tests to understand predispositions to conditions like heart disease and cancer, with companies offering personalized health reports and follow-up consultations. Europe also exhibits strong demand, with countries like France and Spain focusing on preventive healthcare. Many individuals in these regions are using tests to manage genetic conditions such as lactose intolerance and hereditary cancers. In Asia-Pacific, rapid digitalization has fueled growth, especially in countries like China and India, where consumers are increasingly seeking genetic testing services for better health management. In Australia, there has been a noticeable interest in testing for conditions like diabetes, which is becoming more prevalent in urban areas. Latin America has witnessed slower growth, but countries like Brazil are catching up, where genetic testing is used for both disease risk and ancestry tracing. The Middle East shows a more cautious but growing interest, particularly in the UAE and Saudi Arabia, where high-income populations are beginning to explore personalized health testing. Each region is adapting to the technology at its own pace, creating diverse opportunities in the market.

Competitive Scenario:

The direct-to-consumer genetic testing market is being significantly shaped by key players like 23andMe, MyHeritage, and Ancestry.com, who have expanded beyond ancestry testing to offer comprehensive health insights. 23andMe has enhanced its offerings with genetic testing for conditions like Parkinson's and breast cancer, tapping into the growing demand for personalized healthcare. Similarly, MyHeritage and Ancestry.com have added health-related reports to their traditionally ancestry-focused platforms, broadening their consumer base. LabCorp and Quest Diagnostics, established names in medical testing, have ventured into the direct-to-consumer market, providing genetic testing services alongside their regular offerings. Smaller companies like Gene By Gene and DNA Diagnostics Center have been focusing on niche areas, such as rare genetic conditions and forensic testing, while firms like Invitae and Color Genomics are pushing clinical-grade genetic tests for inherited diseases. Meanwhile, Mapmygenome and Pathway Genomics offer personalized health recommendations, integrating genetics with lifestyle planning. Companies like Xcode and Living DNA are capitalizing on the growing interest in wellness by offering DNA-based insights into diet, exercise, and mental health. International players like African Ancestry and Canadian DNA Services are catering to specific regional markets, focusing on ethnicity-based genetic testing. With advancements in technology and an increasing shift toward preventive care, these companies are reshaping the genetic testing landscape.Direct-to-consumer Disease Risk and Health Genetic Test Market Report Scope

The Global Direct-to-consumer Disease Risk and Health Genetic Test Market report is segmented as follows:

By Type,

• Celiac Disease
• Parkinson Disease
• Alzheimer Disease

By Application,

• Online
• Offline

By Region,

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Southeast Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East and Africa

Key Market Players,

• 23andMe
• MyHeritage
• LabCorp
• Myriad Genetics
• Ancestry.com
• Quest Diagnostics
• Gene By Gene
• DNA Diagnostics Center
• Invitae
• IntelliGenetics
• Ambry Genetics
• Living DNA
• EasyDNA
• Pathway Genomics
• Centrillion Technology
• Xcode
• Color Genomics
• Anglia DNA Services
• African Ancestry
• Canadian DNA Services
• DNA Family Check
• Alpha Biolaboratories
• Test Me DNA
• 23 Mofang
• Genetic Health
• DNA Services of America
• Shuwen Health Sciences
• Mapmygenome
• Full Genomes

Research Objectives

• Proliferation and maturation of trade in the global Direct-to-consumer Disease Risk and Health Genetic Test Market.
• The market share of the global Direct-to-consumer Disease Risk and Health Genetic Test Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Direct-to-consumer Disease Risk and Health Genetic Test Market.
• Feasibility study, new market insights, company profiles, investment return, market size of the global Direct-to-consumer Disease Risk and Health Genetic Test Market.